OTCPK:TRVN - Post by User
Post by
GolongGekkoon Feb 16, 2017 12:15pm
81 Views
Post# 25855657
Institutional BUYING - FYI
Institutional BUYING - FYIA number of institutional investors have recently modified their holdings of TRVN. GSA Capital Partners LLP acquired a new position in shares of Trevena during the second quarter worth $344,000. Bourgeon Capital Management LLC raised its position in shares of Trevena by 70.8% in the second quarter. Bourgeon Capital Management LLC now owns 54,300 shares of the biopharmaceutical company’s stock worth $342,000 after buying an additional 22,500 shares during the period. Schwab Charles Investment Management Inc. raised its position in shares of Trevena by 153.5% in the second quarter. Schwab Charles Investment Management Inc. now owns 127,334 shares of the biopharmaceutical company’s stock worth $803,000 after buying an additional 77,100 shares during the period. Alps Advisors Inc. raised its position in shares of Trevena by 28.3% in the second quarter. Alps Advisors Inc. now owns 73,294 shares of the biopharmaceutical company’s stock worth $462,000 after buying an additional 16,169 shares during the period. Finally, Northpointe Capital LLC raised its position in shares of Trevena by 92.6% in the second quarter. Northpointe Capital LLC now owns 379,186 shares of the biopharmaceutical company’s stock worth $2,389,000 after buying an additional 182,261 shares during the period. 74.06% of the stock is owned by institutional investors and hedge funds.